Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort
Gellen, Barnabas, Thorin-Trescases, Nathalie, Thorin, Eric, Gand, Elise, Sosner, Philippe, Brishoual, Sonia, Rigalleau, Vincent, Montaigne, David, Javaugue, Vincent, Pucheu, Yann, Gatault, Philippe, PJournal:
Diabetologia
DOI:
10.1007/s00125-020-05108-5
Date:
February, 2020
File:
PDF, 711 KB
2020
File converter
More search results
More benefits 
